![Legislation Overview: UK Medicines and Medical Devices Act 2021](https://www.regdesk.co/wp-content/uploads/2021/06/uk-1080x675.jpg)
Jun 23, 2021
Europe
The Medicines and Medical Devices Act 2021 (the Act), adopted on February 11, 2021, constitutes one of the basic elements of the UK`s legislation in the sphere of medical devices. The document outlines the rights and responsibilities of a Commissioner of Patient...
Read More
![FDA Guidance on Post-Approval Studies](https://www.regdesk.co/wp-content/uploads/2021/06/Guidance-on-Post-Approval-Studies-1080x650.png)
Jun 4, 2021
FDA
The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of medical devices, has issued a guidance document dedicated to the procedures for handling post-approval studies imposed by premarket approval application orders. The...
Read More
![FDA Announces Medical Device Reporting Changes](https://www.regdesk.co/wp-content/uploads/2019/06/fdaupdates.png)
Jun 25, 2019
North America
The US medical device regulating authority, the FDA, terminated the Alternative Summary Reporting Program, used for reporting for over 10 years. Medical device manufacturers exempted from reporting were informed that they would also be required to submit reports....
Read More
![FDA Issued a Safety Communication on Cybersecurity Vulnerabilities](https://www.regdesk.co/wp-content/uploads/2016/12/fda-1080x675.jpg)
Mar 28, 2019
North America
The medical device regulating authority in the United States, the FDA, issued special warning on cybersecurity threats related to cardiac implantable devices (ICDs). According to the document placed on the official website, the FDA aims to alert both companies and...
Read More